NDC 44206-456-21 Hizentra
Human Immunoglobulin G
NDC Package Code 44206-456-21
The NDC Code 44206-456-21 is assigned to a package of 1 syringe in 1 carton > 5 ml in 1 syringe (44206-456-94) of Hizentra, a plasma derivative labeled by Csl Behring Ag. The product's dosage form is liquid and is administered via subcutaneous form.
NDC Code Structure
- 44206 - Csl Behring Ag
- 44206-456 - Hizentra
- 44206-456-21 - 1 SYRINGE in 1 CARTON
- 44206-456 - Hizentra
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the disclaimer below.
NDC HCPCS Crosswalk
This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.
NDC 44206-456-21 HCPCS crosswalk information with package details and bill units information.
NDC Billing Code | HCPCS Code | HCPCS Code Desc. | Dosage | Package Size | Package Quantity | Billable Units | Billable Units / Pkg |
---|---|---|---|---|---|---|---|
44206045621 | J1559 | Hizentra injection | 100 MG | 5 | 1 | 10 | 10 |
* Please review the disclaimer below.